Re: “ Letter to the Editor: Repurposing of an Antisepsis Drug in COVID-19 Patients,” by Kumar et al.

Abstract

Get full access to this article

View all access options for this article.

References

Kumar

, Pareek

, Kant

: Letter to the Editor: repurposing of an antisepsis drug in COVID-19 patients. Assay Drug Dev Technol, 2021; 19:407-408.

Sharma

, Katoch

, Sarin

, et al.: Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial. Sci Rep, 2017; 7:3354.

Sharma

, Kar

, Misra

, et al.: Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine. Int J Lepr Other Mycobact Dis, 1999; 67:259–269.